ARTICLE | Distillery Therapeutics
Cancer
January 11, 2017 12:54 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) TUG1 could help treat glioblastoma multiforme (GBM). In tissue samples from patients, levels of TUG1 ...
BCIQ Company Profiles
BCIQ Target Profiles